Latest Headlines
PR Newswire
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
8 小时前
PR Newswire
Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
8 小时前
PR Newswire
Timekettle Makes Its First Appearance at MWC 2026, Highlighting the Highly Responsive W4 AI Interpreter Earbuds
9 小时前
PR Newswire
Sportovci ze Švédska a Nizozemska získali medaile na zimních olympijských hrách Milán Cortina 2026, s tím jak se ambasador týmu TCL dostal na stupně vítězů
10 小时前
It's better on the app
👈 Scan the QR code to download
